Table 2.
Patient demographics, injury, vitals, laboratory values, and coagulation function in all patients
| All patients (N = 36) | Reference ranges | |
|---|---|---|
| Demographic data | ||
| Age (years) | 41 ± 18 | |
| Male (%) | 73 | |
| Injury and vitals | ||
| Blunt (%) | 75 | |
| Systolic BP (mm Hg) | 137 ± 27 | |
| Heart rate (beats per min) | 109 ± 14 | |
| Glasgow Coma Score (GCS) | 13 ± 4 | |
| Injury Severity Score (ISS): 0.5‐1 | 13 ± 10 | |
| Mortality, % (N) | 8.3 (3) | |
| Laboratory values | ||
| pH | 7.29 ± 0.12 | 7.35 to 7.45 |
| Base excess (mEq/L) | −3.1 ± 5.6 | −2.0 to 2.0 |
| WBC (×109/L) | 12.2 ± 5.6 | 4.5 to 11 |
| Lactate (mmol/L | 3.8 ± 3.7 | 0.5 to 1 |
| Platelet count (K/μL) | 237 ± 73 | 150 to 450 |
| Coagulation function | ||
| TEG ACT (s) | 109 ± 15 | 80 to 140 |
| TEG angle | 74 ± 4.6 | 66 to 82 |
| TEG MA | 65 ± 4.9 | 52 to 72 |
| TEG LY30 (%) | 1.8 ± 1.6 | 0 to 3 |
Note: Mean and SD values are reported.
Abbreviations: ACT, activated clotting time; MA, maximum amplitude; TEG, thromboelastography.